BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

AGNGvsTHNRETF Comparison

ETF 1

AGNG

Global X Aging Population ETF

This fund is part of

New Consumers & Focus

+1.22%

Full AGNG fund page

VS

ETF 2

THNR

Amplify Weight Loss Drug & Treatment ETF

This fund is part of

Tomorrow's Treatments

+1.34%

Full THNR fund page

Global X Aging Population ETF (AGNG) belongs to the New Consumers & Focus segment. Amplify Weight Loss Drug & Treatment ETF (THNR) is part of the Tomorrow's Treatments segment. AGNG's top 3 sector exposures are Healthcare, Finance and Technology. In contrast, THNR's top sector exposures are Healthcare, AGNG is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.59% for THNR. AGNG is up 4.95% year-to-date (YTD) with +$13M in YTD flows. THNR performs worse with 2.16% YTD performance, and +$2M in YTD flows. Run a side-by-side ETF comparison of AGNG and THNR below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

AGNG vs THNR performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 07/30/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	AGNG THNR	+4.11%+0.22%	+7.07%+5.41%	+4.95%+2.16%	+16.31%+13.67%	+37.15%n/a	+28.43%n/a
Flows	AGNG THNR	-+$769K	+$692K+$769K	+$13M+$2M	+$18M+$2M	+$23M-	+$13M-

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	AGNG THNR	+14.86%+18.15%	+13.13%+17.72%	+12.28%n/a	+13.80%n/a
Max drawdown	AGNG THNR	-4.89%-5.17%	-11.18%-12.38%	-13.73%n/a	-25.40%n/a
Max drawdown duration	AGNG THNR	31d23d	151d160d	323dn/a	1041dn/a

Trading data

Create an account to view trading data

Join for free

	AGNG	THNR
Last sale 7/30/2026 at 7:58 PM	$37.50	$25.87
Previous close 07/30/2026	$37.82	$25.77
Consolidated volume 07/30/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of June 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	AGNG	THNR
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 7/30/2026 at 7:58 PM

Live

Closed

	AGNG	THNR
Last price	$37.50	$25.87
1D performance	-0.83%	+0.38%
AuM	$87.98 M	$5.15 M
E/R	0.5%	0.59%

Characteristics

	AGNG	THNR
Management strategy	Passive	Passive
Provider	Global X	Amplify ETFs
Benchmark	Indxx Aging Population Thematic Index	VettaFi Weight Loss Drug & Treatment Index
N° of holdings	84	20
Asset class	-	-
Trailing 12m distribution yield	Join	Join
Inception date	May 9, 2016	May 21, 2024
ESG	Yes	No

More AGNG data on Trackinsight

More THNR data on Trackinsight

Exposure

Countries

AGNG

USA

55.01%

Switzerland

13.28%

Other

31.7%

THNR

USA

58.22%

Denmark

13.37%

China

11.24%

Other

17.17%

Sectors

AGNG

Healthcare

90.38%

Finance

9.07%

Other

0.55%

THNR

Healthcare

99.22%

Other

0.78%

Diversification

AGNG

Total weight of top 15 holdings out of 15

47.54%

THNR

Total weight of top 15 holdings out of 15

85.06%

Top 15 holdings

Data as of June 30, 2026

AGNG

Novo Nordisk A/S

3.84%

Eli Lilly & Co.

3.82%

AbbVie, Inc.

3.57%

Edwards Lifesciences Corp.

3.42%

Welltower, Inc.

3.29%

Johnson & Johnson

3.19%

Merck & Co., Inc.

3.13%

Ventas, Inc.

3.11%

Roche Holding AG

3.05%

Amgen, Inc.

3.01%

Bristol Myers Squibb Co.

2.92%

Stryker Corp.

2.88%

UCB SA

2.81%

AstraZeneca PLC

2.76%

Medtronic Plc

2.73%

THNR

Novo Nordisk A/S

9.91%

Eli Lilly & Co.

9.45%

Scholar Rock Holding Corp.

5.76%

Hims & Hers Health, Inc.

5.53%

Viking Therapeutics, Inc.

5.43%

AbbVie, Inc.

5.30%

Merck & Co., Inc.

5.01%

Regeneron Pharmaceuticals, Inc.

5.01%

AstraZeneca PLC

5.00%

Arrowhead Pharmaceuticals, Inc.

4.99%

Roche Holding AG

4.95%

Amgen, Inc.

4.90%

Innovent Biologics, Inc.

4.78%

Chugai Pharmaceutical Co., Ltd.

4.55%

Pfizer Inc.

4.49%

Frequently asked questions about AGNG and THNR

How have the AGNG and THNR ETFs performed in 2026?

As of July 30, 2026, AGNG is up 4.95% year-to-date (YTD), while THNR has returned 2.16%. That puts AGNG better performer ahead so far this year.

Which ETF is attracting more investor money: AGNG or THNR?

Year-to-date, the AGNG ETF saw +$13M in flows, compared to +$2M for THNR.

Which ETF is more volatile: AGNG or THNR?

Over the past year, AGNG had a volatility of 13.13%, while THNR experienced 17.72%.

Which ETF is bigger: AGNG or THNR?

As of July 30, 2026, AGNG holds $87.98 M in assets under management (AUM), while THNR manages $5.15 M.

What sectors do the AGNG and THNR ETFs invest in?

AGNG leans toward sectors like Healthcare and Finance. Meanwhile, THNR focuses on Healthcare.

What are the top holdings of the AGNG ETF and THNR ETF?

AGNG top holdings include Novo Nordisk A/S, Eli Lilly & Co. and AbbVie, Inc.. THNR holds in its top three: Novo Nordisk A/S, Eli Lilly & Co. and Scholar Rock Holding Corp..

Which ETF is more diversified: AGNG or THNR?

AGNG holds 84 securities with 47.54% of its assets in the top 15. THNR has 20 securities and a top 15 weight of 85.06%.

A Deep Dive into the New Amplify Weight Loss Drug & Treatment ETF (THNR)

June 7, 2024

THNR

Investing in the Aging Demographics Megatrend

February 28, 2023

AGNG

AGNGvsTHNRETF Comparison

Global X Aging Population ETF

Amplify Weight Loss Drug & Treatment ETF

AGNG vs THNR performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the AGNG and THNR ETFs performed in 2026?

As of July 30, 2026, AGNG is up 4.95% year-to-date (YTD), while THNR has returned 2.16%. That puts AGNG better performer ahead so far this year.

Which ETF is attracting more investor money: AGNG or THNR?

Year-to-date, the AGNG ETF saw +$13M in flows, compared to +$2M for THNR.

Which ETF is more volatile: AGNG or THNR?

Over the past year, AGNG had a volatility of 13.13%, while THNR experienced 17.72%.

Which ETF is bigger: AGNG or THNR?

As of July 30, 2026, AGNG holds $87.98 M in assets under management (AUM), while THNR manages $5.15 M.

What sectors do the AGNG and THNR ETFs invest in?

AGNG leans toward sectors like Healthcare and Finance. Meanwhile, THNR focuses on Healthcare.

What are the top holdings of the AGNG ETF and THNR ETF?

AGNG top holdings include Novo Nordisk A/S, Eli Lilly & Co. and AbbVie, Inc.. THNR holds in its top three: Novo Nordisk A/S, Eli Lilly & Co. and Scholar Rock Holding Corp..

Which ETF is more diversified: AGNG or THNR?

AGNG holds 84 securities with 47.54% of its assets in the top 15. THNR has 20 securities and a top 15 weight of 85.06%.

A Deep Dive into the New Amplify Weight Loss Drug & Treatment ETF (THNR)

Investing in the Aging Demographics Megatrend

The ETF Industry Is Evolving Fast